Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anti-CD40 antibodies for use in prevention of graft rejection

Anti-CD40 antibodies for use in prevention of graft rejection

US Patent 11780927 · Granted Oct 10, 2023

Estimated economic value: $66,678,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-CD40 antibodies for use in treatment of hidradenitis suppurativa2025
Anti-CD40 antibodies for use in treatment of hidradenitis suppurativa2025
Solubilized apyrases, methods and use2025
Uses of piperidinyl-indole derivatives2025
Anti-CD40 antibodies for use in treatment of Sjögren's syndrome2024
Anti-CD40 antibodies for use in treatment of Sjögren's syndrome2024
Uses of piperidinyl-indole derivatives2023
Method of treating transplant rejection with silent Fc variants of anti-CD40 ant2021
Nucleic acids encoding silent Fc variants of anti-CD40 antibodies2019
Nucleic acids encoding silent Fc variants of anti-CD40 antibodies2017
Silent Fc variants of anti-CD40 antibodies2017
Silent Fc variants of anti-CD40 antibodies2015